KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Acquisitions: 2013-2025

Historic Acquisitions for Astrana Health (ASTH) over the last 10 years, with Q3 2025 value amounting to $548.6 million.

  • Astrana Health's Acquisitions rose 6024686.47% to $548.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $548.6 million, marking a year-over-year increase of 23016.92%. This contributed to the annual value of $146.3 million for FY2024, which is 214600.74% up from last year.
  • According to the latest figures from Q3 2025, Astrana Health's Acquisitions is $548.6 million, which was up 6024686.47% from $30.8 million recorded in Q4 2024.
  • Astrana Health's 5-year Acquisitions high stood at $548.6 million for Q3 2025, and its period low was -$350000.0 during Q2 2023.
  • In the last 5 years, Astrana Health's Acquisitions had a median value of $2.5 million in 2021 and averaged $48.0 million.
  • The largest annual percentage gain for Astrana Health's Acquisitions in the last 5 years was 10728000.0% (2022), contrasted with its biggest fall of 22051.28% (2022).
  • Quarter analysis of 5 years shows Astrana Health's Acquisitions stood at $10000.0 in 2021, then soared by 107280.0% to $10.7 million in 2022, then plummeted by 82.88% to $1.8 million in 2023, then surged by 1573.88% to $30.8 million in 2024, then surged by 1682.98% to $548.6 million in 2025.
  • Its last three reported values are $548.6 million in Q3 2025, $30.8 million for Q4 2024, and $909000.0 during Q3 2024.